为您找到相关结果约500个

你是不是要搜索 期刊2015+esmo临床实践指南：弥漫性大b细胞淋巴瘤+(dlbcl)的诊断、治疗与随访 点击跳转

MCD-DLBCL arises from center B cells

High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL

Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter'sTrans-Formed DLBCL and Germinal Center B-Cells

Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) DiffuseLarge B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

HBV messing with the B-cell genome leads to DLBCL

Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)

BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5

Molecular insights into treatment failure in Diffuse Large B Cell Lymphoma (DLBCL)

Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL

PAX5 and circ1857 affected DLBCL progression and B-cell proliferation through regulating GINS1

Examining genetic ancestry in diffuse large B-cell lymphoma (DLBCL)

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options

Prognostic Understanding in Newly Diagnosed Older Adults with Diffuse Large B Cell Lymphoma (DLBCL) orDLBCL/High Grade B-Cell Lymphoma with MYC and BCL2 rearrangements

ESMO 2018personal highlights

为您找到相关结果约500个

共500条页码: 1/34页15条/页